Bellerophon Therapeutics Alpha and Beta Analysis
| BLPHDelisted Stock | USD 0.71 0.01 1.43% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Bellerophon Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Bellerophon Therapeutics over a specified time horizon. Remember, high Bellerophon Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Bellerophon Therapeutics' market risk premium analysis include:
Beta (1.26) | Alpha (1.94) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Bellerophon |
Bellerophon Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Bellerophon Therapeutics market risk premium is the additional return an investor will receive from holding Bellerophon Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bellerophon Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Bellerophon Therapeutics' performance over market.| α | -1.94 | β | -1.26 |
Bellerophon Therapeutics Fundamentals Vs Peers
Comparing Bellerophon Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bellerophon Therapeutics' direct or indirect competition across all of the common fundamentals between Bellerophon Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bellerophon Therapeutics or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Bellerophon Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Bellerophon Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bellerophon Therapeutics to competition |
| Fundamentals | Bellerophon Therapeutics | Peer Average |
| Return On Equity | -1.39 | -0.31 |
| Return On Asset | -0.6 | -0.14 |
| Profit Margin | (2.20) % | (1.27) % |
| Operating Margin | (2.48) % | (5.51) % |
| Current Valuation | (9.32 M) | 16.62 B |
| Shares Outstanding | 12.23 M | 571.82 M |
| Shares Owned By Insiders | 3.97 % | 10.09 % |
Bellerophon Therapeutics Opportunities
Bellerophon Therapeutics Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Bellerophon Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Bellerophon or other pink sheets. Alpha measures the amount that position in Bellerophon Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Bellerophon Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Bellerophon Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bellerophon Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Bellerophon Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Bellerophon Therapeutics. Please utilize our Beneish M Score to check the likelihood of Bellerophon Therapeutics' management manipulating its earnings.
| 13th of November 2023 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 30th of June 2023 Last Quarter Report | View |
Build Portfolio with Bellerophon Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Bellerophon Pink Sheet
If you are still planning to invest in Bellerophon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellerophon Therapeutics' history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |